Abiopharma

Director Ding Kun 🟡 adjusted position in 7.0K shares (1 derivative) of JD.com, Inc. (JD) Transaction Date: Aug 14, 2026 | Filing ID: 097445

(99% Neutral) QUINCE THERAPEUTICS, INC. (QNCX) Files Form 8-K

Mandatory Cash Dividend/ Distribution:

OmniAb - OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company

Register of shareholders, changes and capital status - vesting of RSU units into shares - periodic report amendment

OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company

OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company

Warrants Listing - Structured Warrants: Proposed Issue of Call Warrants

UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2026

LexinFintech Holdings Ltd. to Report Second Quarter 2026 Unaudited Financial Results on August 31, 2026 (Beijing time)

KBR Awarded $60 Million Contract to Accelerate Air and Missile Defense Readiness

Evolution Metals & Technologies Reports Second Quarter 2026 Financial Results and Provides Corporate Update

China Automotive Systems Adds Another National Green Factory To Its Manufacturing Development

Townsquare Announces Strategic Digital Advertising Partnership with Midlands Media Group

Centene Announces Planned Chief Financial Officer Transition